Related Experiment Video
Updated: Sep 19, 2025
09:39
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
8.1K
Injectable biodegradable polysaccharide-based hydrogels for stem cell delivery and cartilage regeneration
Xiaojie Lin1, Ruofan Liu1, Yang Zhou1
1Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA. mzhang@uw.edu.
Journal of Materials Chemistry. B
|June 9, 2025
Summary
A novel injectable hydrogel effectively delivers stem cells for knee osteoarthritis treatment, promoting cartilage regeneration and improving cell survival post-transplantation for enhanced therapeutic outcomes.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedics
Background:
- Current knee osteoarthritis (KOA) treatments primarily manage symptoms, lacking cartilage repair capabilities.
- Stem cell therapy offers potential for tissue regeneration in KOA, but faces challenges in efficient delivery and maintaining cell viability.
- Inefficient stem cell delivery and reduced activity post-transplantation hinder the efficacy of regenerative medicine for KOA.
Purpose of the Study:
- To develop an injectable, cell-compatible polysaccharide hydrogel (Ald-HA/Suc-CS) for enhanced stem cell delivery and cartilage regeneration in KOA.
- To create an in-situ forming hydrogel that supports human adipose-derived stem cell (hADSC) proliferation and chondrogenic differentiation.
- To address challenges of cell leakage and reduced cellular activity in stem cell-based KOA therapies.
Main Methods:
- Development of an injectable hydrogel (Ald-HA/Suc-CS) formed in-situ at physiological temperatures.
- Encapsulation of hADSCs within the hydrogel during the in-situ gelation process for minimally invasive delivery.
- Characterization of the hydrogel's microenvironment, including mechanical properties, pore size, and degradation rate, for optimal hADSC support.
Main Results:
- The injectable hydrogel demonstrated excellent biocompatibility and supported hADSC proliferation.
- Nearly all encapsulated hADSCs remained viable 14 days post-injection within the hydrogel.
- Encapsulated hADSCs showed increased expression of chondrogenic differentiation genes compared to 2D cultures.
Conclusions:
- The developed Ald-HA/Suc-CS hydrogel is a promising platform for efficient and minimally invasive delivery of hADSCs for cartilage regeneration in KOA.
- This injectable hydrogel system can significantly improve the efficacy of cell-based therapies for knee osteoarthritis.
- The hydrogel technology holds potential applicability for other cell-based regenerative medicine applications beyond KOA.
